From what 6 stock analysts predict, the share price for 10X Genomics Inc (TXG) might increase by 22.85% in the next year. This is based on a 12-month average estimation for TXG. Price targets go from $54.00 to $70.00. The majority of stock analysts believe TXG is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 6 Wall Street analysts have assigned TXG 5 buy ratings, 1 hold ratings, and 0 sell ratings. This means that analysts expect 10X Genomics Inc to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on TXG. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
justin bowers Deutsche Bank | Buy | $60.0 | maintained | Feb 7, 2024 |
luke sergott Barclays | Buy | $55.0 | maintained | Jan 25, 2024 |
daniel arias Stifel Nicolaus | Buy | $68.0 | maintained | Jan 19, 2024 |
kyle mikson cfa Canaccord Genuity | Buy | $70.0 | maintained | Jan 8, 2024 |
michael ryskin Bank of America Securities | Hold | $54.0 | maintained | Jan 8, 2024 |
doug schenkel Wolfe Research | Buy | $55.0 | initiatedcoverage | Dec 12, 2023 |
john sourbeer UBS | Hold | $44.0 | maintained | Nov 7, 2023 |
tejas savant Morgan Stanley | Buy | $60.0 | maintained | Nov 6, 2023 |
rachel vatnsdal J.P. Morgan | Buy | $65.0 | maintained | Nov 3, 2023 |
patrick b donnelly Citi | Buy | $60.0 | maintained | Nov 2, 2023 |
daniel brennan TD Cowen | Buy | $55.0 | reiterated | Nov 2, 2023 |
matthew sykes Goldman Sachs | Sell | $30.0 | maintained | Aug 3, 2023 |
mason carrico Stephens | Buy | $65.0 | reiterated | May 18, 2023 |
tycho peterson J.P. Morgan | Buy | $65.0 | maintained | May 4, 2023 |
julia qin J.P. Morgan | Buy | $65.0 | maintained | May 4, 2023 |
brian weinstein William Blair | Hold | None | downgraded | Jul 15, 2022 |
derik de bruin Bank of America Securities | Sell | $35.0 | downgraded | Jul 15, 2022 |
david westenberg Piper Sandler | Buy | $96.0 | initiatedcoverage | Mar 5, 2020 |
In 2023, TXG generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that TXG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TEAM-USD
$216.17
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TWKS-USD
$4.41